PL
LEGN icon

Parkwood LLC’s Legend Biotech LEGN Stock Holding History

Parkwood LLC’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,250
Closed -$587K – 112
2024
Q2 		$587K Sell
13,250
-312
-2% -$14.4K 0.07% 108
2024
Q1 		$761K Buy
13,562
+678
+5% +$40.9K 0.07% 156
2023
Q4 		$775K Sell
12,884
-683
-5% -$43.3K 0.09% 96
2023
Q3 		$911K Buy
13,567
+9,088
+203% +$631K 0.1% 90
2023
Q2 		$309K Buy
+4,479
New +$293K 0.06% 118

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Parkwood LLC's LEGN Position: Q3 2024 in Review

Parkwood LLC sold out of Legend Biotech (LEGN) in Q3 2024, closing a stake of 13,250 shares — an estimated $587K sold.

Parkwood LLC first reported a position in LEGN in Q2 2023 and held it in 5 quarters. The position peaked at $911K in Q3 2023. 208 funds tracked by Wall St. Rank hold LEGN as of Q3 2024.

  • Parkwood LLC reported no remaining Legend Biotech position as of Q3 2024 after selling out during the quarter.
  • Parkwood LLC sold 13,250 Legend Biotech shares in Q3 2024, an estimated $587K.
  • Parkwood LLC first reported a position in Legend Biotech in Q2 2023 and held it in 5 quarters.
  • Parkwood LLC's Legend Biotech position peaked at $911K in Q3 2023.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2024.

Based on Parkwood LLC's 13F filing for Q3 2024, filed 14 Nov 2024.